Matches in Wikidata for { <http://www.wikidata.org/entity/Q37385251> ?p ?o ?g. }
- Q37385251 description "article científic" @default.
- Q37385251 description "article scientifique" @default.
- Q37385251 description "articolo scientifico" @default.
- Q37385251 description "artigo científico" @default.
- Q37385251 description "artículu científicu espublizáu en 2013" @default.
- Q37385251 description "bilimsel makale" @default.
- Q37385251 description "scientific article published on 22 October 2013" @default.
- Q37385251 description "vedecký článok" @default.
- Q37385251 description "vetenskaplig artikel" @default.
- Q37385251 description "videnskabelig artikel" @default.
- Q37385251 description "vědecký článek" @default.
- Q37385251 description "wetenschappelijk artikel" @default.
- Q37385251 description "wissenschaftlicher Artikel" @default.
- Q37385251 description "наукова стаття, опублікована в жовтні 2013" @default.
- Q37385251 description "научни чланак" @default.
- Q37385251 description "مقالة علمية نشرت في 22 أكتوبر 2013" @default.
- Q37385251 name "Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer" @default.
- Q37385251 name "Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer" @default.
- Q37385251 name "Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer." @default.
- Q37385251 type Item @default.
- Q37385251 label "Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer" @default.
- Q37385251 label "Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer" @default.
- Q37385251 label "Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer." @default.
- Q37385251 prefLabel "Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer" @default.
- Q37385251 prefLabel "Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer" @default.
- Q37385251 prefLabel "Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer." @default.
- Q37385251 P1433 Q37385251-E7AACD80-7FAD-4FD5-85B4-237BF0465C79 @default.
- Q37385251 P1476 Q37385251-706B70A0-8EB1-4B05-82CA-24087ECC73AA @default.
- Q37385251 P2093 Q37385251-05FF6F71-268D-47D7-B438-B0AEF62E3D23 @default.
- Q37385251 P2093 Q37385251-4514E0B3-A117-4344-A856-B76C6D09D272 @default.
- Q37385251 P2093 Q37385251-5DF0E84B-54DC-4ABB-B836-439DDD2B0C5E @default.
- Q37385251 P2093 Q37385251-6FBA8490-3658-4F36-B8CF-D25FE0E2721D @default.
- Q37385251 P2093 Q37385251-88A81302-7282-406D-8FDE-3690A16B76F0 @default.
- Q37385251 P2093 Q37385251-96E2EBEC-C6E9-4690-B116-3CEBC44497B8 @default.
- Q37385251 P2093 Q37385251-9DFB0B55-7787-4042-9E24-7B7EF9DE12F8 @default.
- Q37385251 P2093 Q37385251-B1D77337-95E1-4990-9786-2620B427307C @default.
- Q37385251 P2093 Q37385251-BCAD63F8-42A8-4457-BD65-3D0A2341AF8A @default.
- Q37385251 P2093 Q37385251-C6F5526B-E911-4E81-8BDD-73039E20F298 @default.
- Q37385251 P2093 Q37385251-E1086B1B-3C91-4F3A-BF62-7D3FECFC2E09 @default.
- Q37385251 P2093 Q37385251-E2E2C593-AF80-4D03-8B38-56A37512D053 @default.
- Q37385251 P2860 Q37385251-03313BC2-1220-47C4-B7A1-B051FF27E701 @default.
- Q37385251 P2860 Q37385251-057B2CB2-0FB6-4E2B-BE3A-C8D79D81C1A5 @default.
- Q37385251 P2860 Q37385251-080EF168-5FE4-42F7-A1DC-C6A951644676 @default.
- Q37385251 P2860 Q37385251-1B50DE64-3EB3-41EA-946C-EAD295CC624B @default.
- Q37385251 P2860 Q37385251-2FFF6E93-CE50-454B-9073-29FF55D11DB0 @default.
- Q37385251 P2860 Q37385251-38681488-48AA-43E7-A592-967A7FFE3D11 @default.
- Q37385251 P2860 Q37385251-43157B50-7C98-4A69-9D4D-8A1C80E9C482 @default.
- Q37385251 P2860 Q37385251-4326FED0-8B8F-4988-ABDF-9DDA114BCB90 @default.
- Q37385251 P2860 Q37385251-5B96574B-9C1B-474A-B494-F878BF15E042 @default.
- Q37385251 P2860 Q37385251-68B50174-9D9D-4E89-8E60-DB3216E46D56 @default.
- Q37385251 P2860 Q37385251-773868BE-06A3-47EA-AF91-75D0DDF88915 @default.
- Q37385251 P2860 Q37385251-80BF4A39-255F-4C15-8CB8-46B1182C0529 @default.
- Q37385251 P2860 Q37385251-883EFE21-5129-4AE8-98DD-64AE5E72AAC1 @default.
- Q37385251 P2860 Q37385251-8F8C5F3B-2F8C-49FF-A9B5-D263301006F0 @default.
- Q37385251 P2860 Q37385251-95E2D3BE-8F00-41AA-BCB1-54A393876DB0 @default.
- Q37385251 P2860 Q37385251-A10688F9-8E50-4BAA-A2FD-62459BA3D2B6 @default.
- Q37385251 P2860 Q37385251-AC9F591B-5DEA-45B2-89DA-3BDCAE17A1B7 @default.
- Q37385251 P2860 Q37385251-D0F3FD92-0DE1-4A3F-989B-69AB44A091E6 @default.
- Q37385251 P2860 Q37385251-EB7F3E89-496C-44D5-9F91-8C368F788282 @default.
- Q37385251 P2860 Q37385251-F79287A8-3F91-43DD-9772-504663DBAE57 @default.
- Q37385251 P2888 Q37385251-F8997A81-C1DC-41EC-ADF1-4EAE9E836120 @default.
- Q37385251 P304 Q37385251-4EF465FF-8445-4F13-98F2-815AFE50D47C @default.
- Q37385251 P31 Q37385251-26E593AB-61A5-46E0-BDDA-97B9C8FDFD4B @default.
- Q37385251 P356 Q37385251-8E545A8B-81B1-4BF0-BB85-FE1A8A96FD17 @default.
- Q37385251 P407 Q37385251-6BFE1D3B-1B3E-4CF1-B858-084A0DA8F9A9 @default.
- Q37385251 P433 Q37385251-AA48F194-704F-425D-8A3A-86801855EFE3 @default.
- Q37385251 P478 Q37385251-18F1E2EE-9219-42F8-815F-62D37A2B06CC @default.
- Q37385251 P50 Q37385251-15DF424A-DF00-4C40-BDB0-A91F492D3392 @default.
- Q37385251 P50 Q37385251-6444ECD4-C47A-47DD-8CEA-D10700DA4EEF @default.
- Q37385251 P577 Q37385251-12B99E11-F0AE-4EC3-9F9F-26C115F7FE42 @default.
- Q37385251 P698 Q37385251-7205564F-4AA9-4A59-9622-60CB6C1DDE82 @default.
- Q37385251 P921 Q37385251-97C0093D-7296-45DE-BD10-0522FC9331F4 @default.
- Q37385251 P921 Q37385251-F01ECD10-CDC0-4430-A628-A4F9FAD284B0 @default.
- Q37385251 P932 Q37385251-F13ECF8D-28E9-4B3F-8D93-7F3FABF28E31 @default.
- Q37385251 P356 BJC.2013.661 @default.
- Q37385251 P698 24149178 @default.
- Q37385251 P1433 Q326309 @default.
- Q37385251 P1476 "Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer" @default.
- Q37385251 P2093 "A Bruining" @default.
- Q37385251 P2093 "C E Loo" @default.
- Q37385251 P2093 "E H Lips" @default.
- Q37385251 P2093 "H A Warnars" @default.
- Q37385251 P2093 "I A Mandjes" @default.
- Q37385251 P2093 "J Wesseling" @default.
- Q37385251 P2093 "K G Gilhuijs" @default.
- Q37385251 P2093 "L S Rigter" @default.
- Q37385251 P2093 "M J Vrancken Peeters" @default.
- Q37385251 P2093 "P K Doll" @default.
- Q37385251 P2093 "S C Linn" @default.
- Q37385251 P2093 "S Rodenhuis" @default.
- Q37385251 P2860 Q29617404 @default.
- Q37385251 P2860 Q35130819 @default.
- Q37385251 P2860 Q35740423 @default.
- Q37385251 P2860 Q36324120 @default.
- Q37385251 P2860 Q37385321 @default.
- Q37385251 P2860 Q38069421 @default.
- Q37385251 P2860 Q43062601 @default.
- Q37385251 P2860 Q43918762 @default.
- Q37385251 P2860 Q45925101 @default.
- Q37385251 P2860 Q46304664 @default.